An AllTrials project

NCT03399786: An ongoing trial by Regeneron Pharmaceuticals

This trial is completed, but has been granted a delay in reporting its results. It must report results 1 year, 11 months from now.

Full data

Full entry on NCT03399786
Title A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Jan. 18, 2018
Completion date June 10, 2019
Required reporting date June 10, 2022, midnight
Actual reporting date None
Date last checked at July 7, 2020
Days late None